24 May 2013
Keywords: cvt, reports, positive, data, vri, drug, cv
Article | 06 December 2001
CV Technologies of Canada has reported positive results from a Phase IIassessment of CVT-E002, its immunomodulating drug, in the prevention ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.